CRON News and Press, Cronos Group Inc. From 02/26/21

Cronos Group Inc. (CRON) Q4 2020 Results Conference Call February 26, 2021 8:30 AM ET Company Participants Shayne Laidlaw - Investor Relations Kurt Schmidt - CEO Mike Gorenstein - Executive Chairman Jerry Barbato - CFO Xiuming Shum - EVP of Legal and Regulatory Affairs Conference Call Partici...

Cronos Group Inc. (NASDAQ: CRON) released its 2020 fourth quarter and full-year business results for the quarter ending in December. Cronos delivered net revenue increased 133% to $17.0 million in the fourth quarter versus $9.7 million for the same time period in 2019. The net...

Canopy Growth (CGC), HEXO (HEXO), and Aphria (APHA) have joined Cronos (CRON) in a pre-market drag among pot stocks after the latter’s Q4 2020 earnings failed to surpass consensus estimates.Notable pre-market losers in the cannabis space include Canopy Growth, Aphria and Hexo, with ...

Cronos Group (CRON) Q4 results:Revenues: $17.05M (+133.6%), beating estimates by $3.29M. (primarily driven by continued growth in the adult-use market in Canada, sales in the Israeli medical market and growth in its U.S. segment.).Gross loss of $16.7M in Q4 2020 ...

Cronos Group (CRON): Q4 GAAP EPS of -$0.31 misses by $0.23.Revenue of $17.05M (+133.6% Y/Y) beats by $3.29M.Adjusted EBITDA loss of $53.1M in Q4 2020 increased by $1.5M from Q4 2019.Gross margin of -87% vs. -275% in Q4 2019.Press Release For further details see: Cronos Group EPS misses ...

Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the Israeli medical cannabis market Preserves robust balance sheet with approximately USD$1.3 billion in cash and short-term investmen...

Cronos Group (OTC:CRON) is scheduled to announce Q4 earnings results on Friday, February 26th, before market open.The consensus EPS Estimate is -$0.08 and the consensus Revenue Estimate is $13.23MOver the last 1 year, CRON has beaten EPS estimates 75% of the time and has beaten revenue estima...

[[AMCX]], [[AMRX]], [[BLDR]], [[CNK]], [[CRI]], [[CRON]], [[DKNG]], [[EVRG]], [[FL]], [[FLR]], [[LAMR]], [[MODV]], [[NWN]], [[PEG]], [[PNM]], [[QRTEA]], [[RHP]], [[SLCA]], [[SSP]], [[STRA]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable ea...

The marijuana industry now looks extremely promising from an investing standpoint. However, many companies are still struggling with weak financials and shaky fundamentals. Their valuations are stretched, and we think there is a strong possibility of a pullback in the near term. Canopy Growth...

CIBC Capital Markets has downgraded Cronos Group (CRON) to neutral from outperform citing the valuation. However, the analyst John Zamparo has raised the price target to ~$12.50 from $8.00 per share, implying ~1.6% upside to the previous close.Despite the valuations of cannabis stocks hoverin...